【Company Research】YSB (9885 HK) – Digitalizing outside-of-hospital pharmaceutical circulation market in China |
【Company Research】Intron Technology (1760 HK) – 1H23 results below; expect back-loaded in 2H23E |
【Company Research】China Tower (788 HK) – 2Q23 results in-line with expectations; cash flow under temporary pressure |
【Company Research】ZTE (763 HK) – 1H23 earnings lifted by improved gross margin |
【Company Research】Innovent Biologics (1801 HK) – Strong sales growth with improved cost efficiency |
【Company Research】Jiumaojiu (9922 HK) – Tai Er’s OPM and Song are the key drivers |
【Sector Research】China 5G Sector – China telecom sector remains as a defensive play |
【Company Research】Meituan (3690 HK) – Staying vigilant in long-lasting competition |
【Company Research】ENN Energy (2688 HK) – 1H23 results miss amid weak economic recovery and gas cost fluctuation |
【Sector Research】China Auto Sector – 2H23 auto sales could beat amid resilient Jul, Aug |